FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to phenylcyclohexane carboxylic acid substituted amides of the formula (I):
wherein A, D, E and G are similar or different and mean group CH or nitrogen atom; R1 means group CH2-OH or residue of the formula CO-NH2; R2 means alkyl comprising 1-8 carbon atoms that can be broken by oxygen atom, or piperazine comprising residue of the formula NR4 wherein R4 means hydrogen atom, alkyl comprising 1-6 carbon atoms, or cycloalkyl comprising 3-7 carbon atoms wherein alkyl comprising 1-8 carbon atoms can be broken by oxygen atom, substituted with 1-3 hydroxyl groups or residue of the formula -NR5R6 wherein R5 and R6 mean hydrogen atom, or in common with nitrogen atom form morpholine ring; R3 means phenyl ring, and their salts. Also, invention relates to a medicinal agent eliciting effect on inhibitory absorption of adenosine and based on these compounds. Invention provides preparing new compounds and medicinal agent based on thereof for aims treatment of the brain ischemic diseases.
EFFECT: valuable medicinal properties of compounds.
6 cl, 3 tbl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF BENZIMIDAZOLE AND PHARMACEUTICAL COMPOSITIONS COMPRISING PRODRUG OF PROTON PUMP INHIBITOR | 1999 |
|
RU2232159C2 |
QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2 NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS AND USE THEREOF | 2012 |
|
RU2610262C2 |
SUBSTITUTED AZOLES, ANTIVIRAL ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION, SYNTHESIS AND APPLICATION METHOD | 2010 |
|
RU2452735C1 |
SUBSTITUTED IMIDAZOLES, PHARMACEUTICAL COMPOSITION, METHOD OF TREATING DISEASE, ASSOCIATED WITH, AT LEAST, KSP ACTIVITY AND METHOD OF KSP INHIBITION | 2006 |
|
RU2413721C9 |
CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
BORONIC ACID DERIVATIVES | 2018 |
|
RU2793315C2 |
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS | 2012 |
|
RU2668952C2 |
MACROCYCLIC PYRIDAZINONE DERIVATIVES | 2014 |
|
RU2660435C2 |
NOVEL CYCLOPENTANE DERIVATIVES | 2010 |
|
RU2572555C2 |
ANTIBACTERIAL AGENT | 2000 |
|
RU2269525C2 |
Authors
Dates
2005-02-20—Published
2000-05-16—Filed